![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//15168484/0000003800000001/v2_201603160143/S151684841500170X/v2_201603160143/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR1aFJOKb7qLd+WBf18Ptk/O8dVG5SMqADZji5skBxdmL4Eg+W9M/1HLX6WWOJItH9fTBgdwdPEZR3glHibTrvPAkYyjMi4Vjd55uqJ5DGqlkRjnxsYiTDCVHBAPb+c3uF5KJgKx9Yu19zRC8/kXWnMHN6Ds6zmD73kq5Ioodt3NBUa3ChmlLkrLmWBRMQjlKUpU5vh8NPt70tzEUPueps4+UMKJIGHvgVC7vk0IbGgjd78Ub7YIgCdbhdCEpxhTRgh0xNGSd+WSX2g7oP8mFZzQ)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
![Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation](https://www.neurology.org/cms/10.1212/NXI.0000000000200049/asset/2427c45f-1380-45a4-9230-07b1fb102594/assets/graphic/nxi.0000000000200049f1.jpeg)
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig3_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram](https://www.researchgate.net/publication/292707470/figure/fig2/AS:324773960798244@1454443555010/Measurement-of-kappa-k-and-lambda-l-light-chains-in-free-and-total-assays-Total.png)
Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram
![Comparison of kappa FLC, lambda FLC, and kappa/lambda FLC ratios in... | Download Scientific Diagram Comparison of kappa FLC, lambda FLC, and kappa/lambda FLC ratios in... | Download Scientific Diagram](https://www.researchgate.net/publication/5930043/figure/fig1/AS:216390800809984@1428602995144/Comparison-of-kappa-FLC-lambda-FLC-and-kappa-lambda-FLC-ratios-in-patients-with-and.png)
Comparison of kappa FLC, lambda FLC, and kappa/lambda FLC ratios in... | Download Scientific Diagram
![Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS](https://thebiomedicalscientist.net/sites/default/files/web_28-29_hires-cmyk-retouched-science_photo_library_c0491397.jpg)
Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS
![Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine](https://www.thelancet.com/cms/asset/394499a6-26d1-4062-a2b0-fa2746e586a8/fx1.jpg)
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
![Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/97343738-f909-4e28-94e4-b624973cd798/hsr2113-fig-0001-m.jpg)
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
![Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis – a pilot study | BMC Cancer | Full Text Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis – a pilot study | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1471-2407-7-185/MediaObjects/12885_2007_Article_835_Fig1_HTML.jpg)
Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis – a pilot study | BMC Cancer | Full Text
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine](https://www.thelancet.com/cms/attachment/0a6d90ba-3e1a-443c-868c-fdb5b660e884/gr1.jpg)
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)